Revenues of Q32 Bio Inc. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Q32 Bio Inc. annual and quarterly Revenues in USD history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • Q32 Bio Inc. Revenues for the quarter ending 31 Dec 2024 was $0.
  • Q32 Bio Inc. Revenues for the twelve months ending 31 Dec 2024 was $0.
  • Q32 Bio Inc. annual Revenues for 2025 was $53,737,000.
  • Q32 Bio Inc. annual Revenues for 2024 was $0.
  • Q32 Bio Inc. annual Revenues for 2023 was $6,651,000.
Source SEC data
View on sec.gov
Revenues, Annual (USD)
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)

Q32 Bio Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $53,737,000 +$53,737,000 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $0 +$6,651,000 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $6,651,000 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2018 $3,684,000 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2019 2018 FY

Q32 Bio Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 $0 +$14,662,000 01 Oct 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 $14,662,000 $0 -$1,859,000 -100% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $12,803,000 $0 -$3,205,000 -100% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $9,598,000 $0 -$2,947,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $6,651,000 $14,662,000 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $1,859,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $3,205,000 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $2,947,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2018 $823,372 01 Jan 2018 31 Mar 2018 10-Q 14 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.